Adagio Medical Holdings, Inc.
ADGMNASDAQHealthcareMedical - Devices
Previous close
$0.6491
+$0.015 · +2.37%
ADGM company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
21
Expensive
Momentum
28
Weakening
Sentiment
53
Mixed
Risk resilience
34
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAdagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Todd Usen
- Listed since
- Aug 1, 2024
- Employees
- 41
Market position
Day range
Current $0.6491
52-week range
Current $0.6491
- Open
- $0.6499
- Previous close
- $0.6341
- Volume
- 351.11K
- 3.86× average
- Average volume
- 90.87K
- Average daily volume
- Market cap
- 14.42M USD
- Beta
- -0.19
- Market reference 1
- 50-day average
- $0.6113
- +6.18% above average
- 200-day average
- $0.9059
- -28.35% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 21.89M USD
- EV / EBITDA
- -1.03×
- Earnings yield
- -145.50%
- Free cash flow yield
- -112.46%
Profitability & efficiency
- Return on equity
- -202.26%
- Return on assets
- -57.99%
- Return on invested capital
- -62.23%
Financial health
- Current ratio
- 2.44×
- Altman Z-score
- -6.4
- Piotroski F-score
- 2 of 9
Earnings
- Latest fiscal-year EPS
- -1.51
- FY2025
- Latest fiscal-year revenue
- 0 USD
- FY2025 · -100.00% year over year
- Next fiscal-year EPS consensus
- -1.09
- FY2026 · 2 analysts
- Next fiscal-year revenue consensus
- 1.53M USD
- FY2027 · 2 analysts
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$3.00
362.18% upsidePrice history unavailable
High $3.00Average $3.00Low $3.00ADGM news
ADGM peers
ETFs holding ADGM
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research ADGMresearch.disclaimer